Release Date: 23/12/15 12:28 Summary: Technical Expert Review on Xped Price Sensitive: Yes Download Document 1.53MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%